DURHAM, N.C. (AP) _ Precision BioSciences Inc. (DTIL) on Wednesday reported a loss of $11.3 million in its third quarter.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of 19 cents.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

The genome editing company posted revenue of $24 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $8.5 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DTIL at https://www.zacks.com/ap/DTIL

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News